615 related articles for article (PubMed ID: 32943787)
21. Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong.
Cheng VCC; Wong SC; Chen JHK; Yip CCY; Chuang VWM; Tsang OTY; Sridhar S; Chan JFW; Ho PL; Yuen KY
Infect Control Hosp Epidemiol; 2020 May; 41(5):493-498. PubMed ID: 32131908
[TBL] [Abstract][Full Text] [Related]
22. Evolving Epidemiological Characteristics of COVID-19 in Hong Kong From January to August 2020: Retrospective Study.
Kwok KO; Wei WI; Huang Y; Kam KM; Chan EYY; Riley S; Chan HHH; Hui DSC; Wong SYS; Yeoh EK
J Med Internet Res; 2021 Apr; 23(4):e26645. PubMed ID: 33750740
[TBL] [Abstract][Full Text] [Related]
23. Overdispersion in COVID-19 increases the effectiveness of limiting nonrepetitive contacts for transmission control.
Sneppen K; Nielsen BF; Taylor RJ; Simonsen L
Proc Natl Acad Sci U S A; 2021 Apr; 118(14):. PubMed ID: 33741734
[TBL] [Abstract][Full Text] [Related]
24. High infectiousness immediately before COVID-19 symptom onset highlights the importance of continued contact tracing.
Hart WS; Maini PK; Thompson RN
Elife; 2021 Apr; 10():. PubMed ID: 33899740
[TBL] [Abstract][Full Text] [Related]
25. In-Flight Transmission of SARS-CoV-2.
Choi EM; Chu DKW; Cheng PKC; Tsang DNC; Peiris M; Bausch DG; Poon LLM; Watson-Jones D
Emerg Infect Dis; 2020 Nov; 26(11):2713-2716. PubMed ID: 32946370
[TBL] [Abstract][Full Text] [Related]
26. The first laboratory-confirmed imported infections of SARS-CoV-2 in Sudan.
Aljak ER; Eldigail M; Mahmoud I; Elhassan RM; Elduma A; Ibrahim AA; Ali Y; Weaver SC; Ahmed A
Trans R Soc Trop Med Hyg; 2021 Jan; 115(1):103-109. PubMed ID: 33319246
[TBL] [Abstract][Full Text] [Related]
27. Superspreading events of SARS-CoV-2 in Paris: A retrospective analysis of data from the first wave of COVID-19 in 2020.
Deslandes A; Calba C; Mahdjoub S; Zhu-Soubise A; Mathey D; Ardoin A
J Infect Public Health; 2021 Nov; 14(11):1733-1738. PubMed ID: 34715427
[TBL] [Abstract][Full Text] [Related]
28. Effective control of SARS-CoV-2 transmission in Wanzhou, China.
Shi Q; Hu Y; Peng B; Tang XJ; Wang W; Su K; Luo C; Wu B; Zhang F; Zhang Y; Anderson B; Zhong XN; Qiu JF; Yang CY; Huang AL
Nat Med; 2021 Jan; 27(1):86-93. PubMed ID: 33257893
[TBL] [Abstract][Full Text] [Related]
29. Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission.
Aggarwal D; Page AJ; Schaefer U; Savva GM; Myers R; Volz E; Ellaby N; Platt S; Groves N; Gallagher E; Tumelty NM; Le Viet T; Hughes GJ; Chen C; Turner C; Logan S; Harrison A; ; Peacock SJ; Chand M; Harrison EM
Nat Commun; 2022 Feb; 13(1):1012. PubMed ID: 35197443
[TBL] [Abstract][Full Text] [Related]
30. Findings from the first public COVID-19 temporary test centre in Hong Kong.
Leung WLH; Yu ELM; Wong SC; Leung M; Lee LLY; Chung KL; Cheng VCC
Hong Kong Med J; 2021 Apr; 27(2):99-105. PubMed ID: 33790053
[TBL] [Abstract][Full Text] [Related]
31. Analysis of SARS-CoV-2 Transmission in Different Settings, Brunei.
Chaw L; Koh WC; Jamaludin SA; Naing L; Alikhan MF; Wong J
Emerg Infect Dis; 2020 Nov; 26(11):2598-2606. PubMed ID: 33035448
[TBL] [Abstract][Full Text] [Related]
32. Quantifying the impact of quarantine duration on COVID-19 transmission.
Ashcroft P; Lehtinen S; Angst DC; Low N; Bonhoeffer S
Elife; 2021 Feb; 10():. PubMed ID: 33543709
[TBL] [Abstract][Full Text] [Related]
33. Genomic epidemiology of SARS-CoV-2 under an elimination strategy in Hong Kong.
Gu H; Xie R; Adam DC; Tsui JL; Chu DK; Chang LDJ; Cheuk SSY; Gurung S; Krishnan P; Ng DYM; Liu GYZ; Wan CKC; Cheng SSM; Edwards KM; Leung KSM; Wu JT; Tsang DNC; Leung GM; Cowling BJ; Peiris M; Lam TTY; Dhanasekaran V; Poon LLM
Nat Commun; 2022 Feb; 13(1):736. PubMed ID: 35136039
[TBL] [Abstract][Full Text] [Related]
34. Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset.
Cheng HY; Jian SW; Liu DP; Ng TC; Huang WT; Lin HH;
JAMA Intern Med; 2020 Sep; 180(9):1156-1163. PubMed ID: 32356867
[TBL] [Abstract][Full Text] [Related]
35. Role of presymptomatic transmission of COVID-19: evidence from Beijing, China.
Zhang Y; Muscatello D; Tian Y; Chen Y; Li S; Duan W; Ma C; Sun Y; Wu S; Ge L; Yang P; Jia L; Wang Q; MacIntyre CR
J Epidemiol Community Health; 2021 Jan; 75(1):84-87. PubMed ID: 32855261
[TBL] [Abstract][Full Text] [Related]
36. [Epidemiological aspects, clinic and control mechanisms of SARS-CoV-2 pandemic: Situation in Spain].
Garcia-Alamino JM
Enferm Clin (Engl Ed); 2021 Feb; 31():S4-S11. PubMed ID: 32419771
[TBL] [Abstract][Full Text] [Related]
37. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions.
Riley S; Fraser C; Donnelly CA; Ghani AC; Abu-Raddad LJ; Hedley AJ; Leung GM; Ho LM; Lam TH; Thach TQ; Chau P; Chan KP; Lo SV; Leung PY; Tsang T; Ho W; Lee KH; Lau EM; Ferguson NM; Anderson RM
Science; 2003 Jun; 300(5627):1961-6. PubMed ID: 12766206
[TBL] [Abstract][Full Text] [Related]
38. Superspreading Event of SARS-CoV-2 Infection at a Bar, Ho Chi Minh City, Vietnam.
Chau NVV; Hong NTT; Ngoc NM; Thanh TT; Khanh PNQ; Nguyet LA; Nhu LNT; Ny NTH; Man DNH; Hang VTT; Phong NT; Que NTH; Tuyen PT; Tu TNH; Hien TT; Minh NNQ; Hung LM; Truong NT; Yen LM; Rogier van Doorn H; Dung NT; Thwaites G; Dung NT; Van Tan L;
Emerg Infect Dis; 2021 Jan; 27(1):310-4. PubMed ID: 33063657
[TBL] [Abstract][Full Text] [Related]
39. Reopening International Borders without Quarantine: Contact Tracing Integrated Policy against COVID-19.
Yu Z; Zhu X; Liu X; Wei T; Yuan HY; Xu Y; Zhu R; He H; Wang H; Wong MS; Jia P; Guo S; Shi W; Chen W
Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299945
[TBL] [Abstract][Full Text] [Related]
40. Transmission Dynamics of the Delta Variant of SARS-CoV-2 Infections in South Korea.
Hwang H; Lim JS; Song SA; Achangwa C; Sim W; Kim G; Ryu S
J Infect Dis; 2022 Mar; 225(5):793-799. PubMed ID: 34865022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
